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Abstract
Background: Campylobacter species are the most prevalent bacterial pathogen causing acute enteritis worldwide.
In contrast to Campylobacter jejuni, about 5 % of Campylobacter coli strains exhibit susceptibility to restriction
endonuclease digestion by DpnI cutting specifically 5’-GmATC-3’ motifs. This indicates significant differences in DNA
methylation between both microbial species.
The goal of the study was to analyze the methylome of a C. coli strain susceptible to DpnI digestion, to identify its
methylation motifs and restriction modification systems (RM-systems), and compare them to related organisms like
C. jejuni and Helicobacter pylori.
Results: Using one SMRT cell and the PacBio RS sequencing technology followed by PacBio Modification and Motif
Analysis the complete genome of the DpnI susceptible strain C. coli BfR-CA-9557 was sequenced to 500-fold
coverage and assembled into a single contig of 1.7 Mbp. The genome contains a CJIE1-like element prophage and
is phylogenetically closer to C. coli clade 1 isolates than clade 3. 45,881 6-methylated adenines (ca. 2.7 % of genome
positions) that are predominantly arranged in eight different methylation motifs and 1,788 4-methylated cytosines
(ca. 0.1 %) have been detected. Only two of these motifs correspond to known restriction modification motifs.
Characteristic for this methylome was the very high fraction of methylation of motifs with mostly above 99 %.
Conclusions: Only five dominant methylation motifs have been identified in C. jejuni, which have been associated
with known RM-systems. C. coli BFR-CA-9557 shares one (RAATTY) of these, but four ORFs could be assigned to
putative Type I RM-systems, seven ORFs to Type II RM-systems and three ORFs to Type IV RM-systems. In
accordance with DpnI prescreening RM-system IIP, methylation of GATC motifs was detected in C. coli BfR-CA-9557.
A homologous IIP RM-system has been described for H. pylori. The remaining methylation motifs are specific for C.
coli BfR-CA-9557 and have been neither detected in C. jejuni nor in H. pylori.
The results of this study give us new insights into epigenetics of Campylobacteraceae and provide the groundwork
to resolve the function of RM-systems in C. coli.
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Background
Campylobacteriosis is the most prevalent form of bacter-
ial acute enteritis worldwide. In symptomatic cases it is
characterized by a prodromal phase with fever, vomiting,
and headaches followed by watery or bloody diarrhea
and abdominal cramps [1, 2]. In consequence of acute
enteritis, extraintestinal post-infectious sequelae, namely,
the Guillain-Barré syndrome, inflammatory bowel dis-
ease, and reactive arthritis may occur [3, 4]. The average
incidence reported in the European Union was 64.8 per
100,000 population in 2013 [5], in the USA 14.3 cases
per 100,000 population in 2012, and in China 161 cases
per 100,000 population in urban areas compared to 37
cases per 100,000 population in rural areas [6]. In Eur-
ope, 80.6 % were reported to have been caused by Cam-
pylobacter jejuni and 7.1 % by Campylobacter coli [5].
C. coli is phylogenetically subdivided into three clades
[7, 8]: clade 1 isolates commonly colonize swine but can
also be isolated from poultry and humans, although less
frequently. Clades 2 and 3 are typically isolated from en-
vironmental waters [8, 9].
At the moment, seven completed C. coli chromosomal
genome sequences [10–13], several scaffold genomes,
and various contigs have been deposited in the NCBI
Genome database [14–17]. The completed genome se-
quences, range from 1.685 to 1.872 Mb, have a G + C
content of about 31 to 32 %, and contain 1715 – 1970
predicted genes including 1642 – 1861 protein coding
ORFs [10–13].
One of the major epigenetic mechanisms in prokary-
otes is DNA methylation [18]. DNA methylation pat-
terns influence gene expression [19], through silencing
of transcription [20, 21] as well as DNA replication initi-
ation [22, 23] and mismatch repair [24]. DNA methyla-
tion also serves as a protection of the host genome
against extraneous DNA [18] through restriction-
modification systems (RM-systems). RM-systems consist
of two components: (i) a restriction endonuclease that
recognizes a specific DNA motif and (ii) a cognate DNA
methyltransferase that methylates the same DNA, pre-
venting its cleavage by the restriction endonuclease [25].
The majority of RM-systems can be categorized into
four types [25–29]:
Type I RM-systems typically consist of three types of
subunits: two restriction endonuclease subunits (R),
which facilitate DNA cleavage, one specificity subunit
(S) for recognition of specific DNA sequence motifs, and
two DNA methylase subunits (M) that catalyse N6 aden-
ine methylation [30, 31]. This composition enables Type
I RM-systems to digest unmethylated DNA, whereas
hemimethylated DNA is further methylated and fully
methylated DNA is insusceptible to restriction [32].
Type II RM-systems are mostly composed of two ho-
modimeric R subunits and a separated M subunit. The R
and M subunits recognize the same DNA motif, which
is typically a 4–8 bp palindrome [33].
Type III RM-systems are comprised of two modifica-
tion (Mod) subunits and two restriction (R) subunits.
Type III RM-systems must bind to two inversely ori-
ented copies of its 5–6 bp asymmetric recognition motif.
Cleavage of unmethylated DNA typically occurs 25–
27 bp away from the binding sites [34].
Type IV RM-systems consist of two separate R sub-
units cleaving DNA that contains methylated, hydroxy-
methylated or glucosyl-hydroxymethylated cytosines.
Cleavage typically occurs 30 bp away from one of the
binding sites [35]. Furthermore, there exist many orphan
DNA methylases that are not part of a RM-system e.g.
DNA adenine methylase (Dam) and cell cycle-regulated
DNA methyltransferase (CcrM) [29].
It must be considered that the genes encoding for par-
ticular components of a RM-system are diverse within
microbial species i.e. C. jejuni and C. coli [36–38]. In C.
jejuni the putative Type I RM-system locus (genes
cj1549–cj1553; hsd locus) reveals significant diversity re-
garding gene order, chromosomal location, intervening
ORFs and gene sequence leading to the classification of
the C. jejuni hsd loci into at least three families, namely
the IAB, IC, and IF family. Especially sequence variations
in the hsdS gene suggest at least 30 different target se-
quence specificities and therewith differences in DNA
methylation [39]. Holt and coworkers demonstrated that
cj1051c (cjeI) encodes an active restriction-modification
Type IIG enzyme in C. jejuni that significantly decreases
transformation efficiency with plasmids [40]. Addition-
ally it was shown that Type IIS restriction modification
enzyme Cj0030/Cj0031 is subject to phase variable gene
expression due to mutations in polyC/G tracts [41–43].
Additionally cj0139/cj0140 encode a putative 5-
methylcytosine-restriction system, cj0690c a Type II
RM-system and cj0979c a nuclease that could be part of
a RM-system [41, 42].
Furthermore it was shown for C. jejuni that gene prod-
uct of cj1461 is a N6-adenine-specific DNA methyltrans-
ferase that is not a Dam homologue and not part of a
RM-system. Knockout of cj1461 affects flagellar appear-
ance, motility, adherence, and invasion indicating its role
for epigenetic control of proteins involved in these pro-
cesses [44]. Further non-ubiquitous modification/meth-
yltransferase gene loci have been observed in C. jejuni
ST-677 isolates, namely fixL (cjj5070_14950c) that
showed homology with DNA adenine/modification
methylases in Campylobacter rectus, a homolog of
iceA1/nlaIII (cjj5070_14940c), cjj5070_14910c predicted
as ulcer associated adenine-specific DNA methyltrans-
ferase, which is an ortholog of the CATG-specific meth-
yltransferase hpyIM of H. pylori, and the orphan DNA
methyltransferase in ORF cjj5070_08940 [45]. Three
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strain-specific RM-systems have been reported for C.
jejuni ST403 complex: R. HinPI restriction endonuclease
(cje135_03870), Modification methylase Hhal
(cje135_03865), and R.Pab1 restriction endonuclease
(cje135_02348) [46].
In contrast to C. coli, Type III RM-systems have been
reported for C. jejuni subsp. jejuni, C. jejuni subsp. doylei,
Campylobacter lari, and Campylobacter upsaliensis [47].
Until to date the methylomes of C. jejuni subsp. jejuni
(3 isolates) and of the related microbial species Helico-
bacter pylori (2 isolates) have been analyzed [48–50], but
so far no C. coli methylome has been examined.
Studies performing isoschizomer digestion assays indi-
cated differences in methylation at GATC sites in gen-
omic DNA of C. coli isolates, which suggested host-
associated DNA modification systems [51, 52].
In this study we analyzed the first methylome of C. coli
using SMRT DNA sequencing. This approach facilitates
analysis of methylation motifs as well as RM-system
gene loci in parallel. For SMRT sequencing a C. coli iso-
late was selected, which was tested positive for GATC
site methylation isoschizomer digestion assay screening.
Results and discussion
SMRT sequencing and annotation
Screening of 50 C. coli isolates performing 5’-G(m)ATC-
3’-specific isoschizomer digestion assays revealed six
bacterial isolates showing Dam activity. Of these six iso-
lates, the isolate BfR-CA-9557 was selected for SMRT
sequencing, since it reproducibly tested positive in five
biological independent analyses. Furthermore, its origin
from broiler hearts sampled at a retail store in Berlin,
Germany, indicates its relevance for food hygiene and
thus for the infection of humans.
MLST typing revealed sequence type ST-1589 and
clonal complex CC-828. Accordingly, it is a potentially
human pathogenic isolate of clade 1.
Susceptibility testing indicated a quinolone resistant
phenotype (zone diameter 0 mm in disc diffusion; min-
imal inhibition concentration (MIC) measured by broth
microdilution: 16 μg/ml ciprofloxacin, 32 μg/ml nalidixic
acid). In contrast, the isolate was tested susceptible for
macrolides, tetracyclines and aminoglycosides (MIC
values: 2 μg/ml erythromycin, <=0,5 μg/ml tetracycline,
1 μg/ml gentamicin, 2 μg/ml streptomycin).
Sequencing of the C. coli isolate using one Pacific Bio-
science SMRT cell resulted in 74,742 continuous long
reads (CLR) with an average (total) length of 14,514
(1.08°109) base pairs (Additional file 1: Figure S1).
142,135 subreads (i.e. individual fragments) of high qual-
ity and an average length of 7,602 bp could be extracted
from the CLRs.
Utilizing the Pacific Bioscience high-quality de novo
genome assembly algorithm (HGAP.2), we obtained a
single polished contig of 1,720,506 base pairs with an
average 500-fold coverage and a confidence score of
>99.99 % (Additional file 2: Figure S2). The G + C con-
tent of the contig was 31.4 % and the most closely re-
lated genome sequence available in the NCBI genome
database was that of C. coli 15–537360 (taxonomy ID
1358410, 87 % coverage). No plasmids were detected in
this isolate.
Application of the NCBI/RAST/Prodigal annotation
pipelines resulted in 1637/1769/1797 predicted coding
sequences and 275/366/453 (16.8/20.7/25.2 %) predicted
hypothetical proteins. (GenBank ID: CP011777, Add-
itional files 3 and 4). Furthermore, 54 RNA genes (44
tRNA/9 rRNA/1 ncRNA) were predicted by NCBI, 52
RNAs (43 tRNA/9 rRNA) by RAST, and 54 RNAs (44
tRNA/9 rRNA/1 tmRNA) by Prodigal.
The RAST subsystem coverage was 57 % (1003 genes),
of which amino acid metabolism (296 of 1557 associated
terms, 19.0 %), protein metabolism (216 terms, 13.9 %),
and cofactors, vitamins, prosthetic groups, and pigments
(144, 9.2 %) represented the largest groups (Fig. 1).
Figure 2a shows a comparison of the BfR-CA-9557
genome sequence to other C. coli genomes (76339, clade
3 and RM4661, clade 1) using the Artemis tool. Here,
homologous regions as identified by BLAST are indi-
cated by red (aligned in the same direction) or blue line
segments (opposite direction). It can be seen that C. coli
76339 mainly shows three stretches of inverse homolo-
gous regions to BfR-CA-9557 and lacks similarity in the
region of the identified CJIE1 (green box, see also
below). RM4661 displays a long stretch of close hom-
ology with minor gaps, but also inverse homologous seg-
ments within the plasmid and the beginning and end of
the chromosome. A similar pattern can be observed for
the comparison of BFR-CA-9557 to C. jejuni NCTC
11168 (Fig. 2b). This indicates that C. coli BfR-CA-9557
is phylogenetically closer to clade 1 and therewith to C.
jejuni islolates than to clade 3 C. coli isolates.
Poly-G/C tracts and the capsular polysaccharid gene locus
Analysis of poly-G/C tracts within the contig of BfR-
CA-9557 revealed 17 locations with homopolymeric
stretches of at least eight G or C nucleotides
(Tables 1 & 2). Most of these tracts occur in the
vicinity of hypothetical proteins, however, two motifs
could be identified within the capsular polysaccharid
gene locus (cps) close to ORFs identified as glycosyl-
transferases (EC 2.4.99.-) by RAST. Other ORFs with
neighboring poly-G/C motifs comprise e.g. transfer-
ases and ligases.
The cps locus of BfR-CA-9557 ranges from 1,656,271
to 1,691,672 (1,660,702-1,686,508 excluding flanking kps
regions). Spanning 35,401 bp and encoding 29 ORFs
(25,806 bp; 21 ORFs; excluding flanking kps regions) it
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Amino Acids and Derivatives (19%)
Protein Metabolism (13.9%)
Cofactors, Vitamins, Prosthetic Groups, Pigments (9.2%)
Cell Wall and Capsule (6.9%)
Carbohydrates (5.9%)
Motility and Chemotaxis (5.7%)
RNA Metabolism (4.6%)
Respiration (4.6%)
Fatty Acids, Lipids, and Isoprenoids (4.5%)
Virulence, Disease and Defense (4.3%)
Iron acquisition and metabolism (3.3%)
Membrane Transport (3.3%)




Regulation and Cell signaling (1.1%)
Nitrogen Metabolism (0.8%)
Cell Division and Cell Cycle (0.6%)
Potassium metabolism (0.5%)
Fig. 1 Pie chart representing RAST subsystems identified in the BFR-CA-9557 genome. The 20 most abundant subsystems on the “category” level








Fig. 2 Comparison of C. coli BFR-CA-9557 genome to those of C. coli RM4661 and 76339 a as well as C. jejuni NCTC 11168 b using the Artemis Comparison
Tool (ACT). Comparison of the BFR-CA-9577 genome to those of C. coli clade 1 strain RM4661 and C. coli clade 3 strain 76339 as well as to the genome of
C. jejuni NCTC 11168 indicates that the clade 1 strain BFR-CA-9577 genome organization is more related to C. coli clade 1 and C. jejuni strains than to clade
3 strains. The CJIE1-homologue prophage in the BFR-CA-9557 genome is indicated in green
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is of comparable size to the largest known other Cam-
pylobacter cps cluster, which measures 38 kb excluding
flanking kps regions (C. jejuni strain X) [53]. The cps
loci of different C. coli and C. jejuni strains are very vari-
able in size and gene content and there are only three
genes that are comparatively conserved: the capsular
polysaccharide export system periplasmic protein gene
KpsD, the GDP-mannose 4,6-dehydratase gene and the
capsular polysaccharide biosynthesis/export periplasmic
protein wcbA/kpsC. The highest sequence similarities
exist to the cps clusters of C. coli strains RM4661 (query
coverage 71 %, identity 99 %) and FB1 (query coverage
54 %, identity 99 %). Compared to the cps locus of strain
X, query coverage of 28 % (identity 87 %) was observed.
The genes for kpsC, hddC, gmhA2, hddA, dmhA, fcl-1,
fcl-2, hypothetical protein x.25 and kpsF are present in
both cps clusters.
N-linked flagellar glycosylation locus
The N-linked flagellar glycosylation locus extends from
1,319,815-1,332,144 (12,329 bp). It consist of 10 ORFs
and is 99 % identical to the corresponding locus in other
C. coli genomes e.g. RM4661 (clade 1) or 76339 (clade
3). In comparison to other C. jejuni strains (e.g. M1 and
81116), insertion of the lipid carrier UDP-N-acetylgalac-
tosaminyltransferase gene and an α-1,4-N-acetylgalacto-
samine transferase PglH gene was observed.
Directly upstream of the N-linked flagellar glycosyla-
tion locus the lipooligosaccharide biosynthesis locus
(LOS locus) is located. The LOS locus extends from the
UDP-glucose 4-epimerase gene galE to the D-glycero-D-
manno-heptose 1,7-bisphosphate phosphatase gene rfaD.
The LOS locus is one of the more variable regions in
Campylobacter genomes. LOS loci containing 8
(RM2095) to 19 (81116) ORFs have been described and
Table 1 Positions of poly-G tracts in the BFR-CA-9557 genome
Poly G on forward strand Pos. rel. to ORF location
Position Length RAST annotation of closest ORF ATG STOP Start Stop Strand
46933 9 hypothetical protein −52 −2292 46985 49225 +
258726 10 FIG 00470070: hypothetical protein −15 −1924 258741 260650 +
689956 10 UDP-N-acetylmuramoylalanine–D-glutamate ligase (EC 6.3.2.9) −6 −1232 691179 689971 -
851085 10 FIG 00470965: hypothetical protein 556 −671 850529 851756 +
1562460 10 Putative transferase −48 −590 1562508 1563050 +
1565336 9 FIG 00469667: hypothetical protein 251 −423 1565085 1565759 +
1575332 10 Motility accessory factor 167 −1780 1575165 1577112 +
1645063 9 Ferrous iron transport protein B 1576 −269 1643487 1645332 +
Poly-G/C tracts were searched in the BFR-CA-9557 genome using regular expression describing at least 8 consecutive G/C. The first two columns denote the genome location
and length of the expression found. Column 3 shows the RAST annotation of the ORF closest to the homopolymeric stretch. Column 4 and 5 represent the relative position
of the stretch to the ORF’s start (4) and Stop codon (5), with negative numbers representing upstream locations. Columns 6 to 8 denote the location and orientation of
the ORF
Table 2 Positions of poly-C tracts in the BFR-CA-9557 genome
Poly C on forward strand pos. rel. to ORF location
Position Length RAST annotation of closest ORF ATG STOP Start Stop Strand
442261 11 Putative lipoprotein of ferric iron transporter system 139 −3 442254 442132 -
1099189 10 hypothetical protein 739 −7 1099187 1098459 -
1257487 9 Phosphoglycerol transferase 1728 −256 1257735 1255767 -
1427910 9 Filamentous haemagglutinin domain protein 1554 −9 1427911 1426364 -
1547848 9 FIG 00469527: hypothetical protein 637 −596 1548436 1547219 -
1587049 8 hypothetical protein 679 −575 1587617 1586377 -
1607917 9 FIG 00470049: hypothetical protein 2305 34 1607875 1605620 -
1660758 9 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-) 64 −620 1661370 1660702 -
1668862 8 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase (EC 2.4.99.-) 40 −1587 1670442 1668829 -
Poly-G/C tracts were searched in the BFR-CA-9557 genome using regular expression describing at least 8 consecutive G/C. The first two columns denote the genome location
and length of the expression found. Column 3 shows the RAST annotation of the ORF closest to the homopolymeric stretch. Column 4 and 5 represent the relative position
of the stretch to the ORF’s start (4) and Stop codon (5), with negative numbers representing upstream locations. Columns 6 to 8 denote the location and orientation of
the ORF
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depending on gene content and organization 19 different
LOS classes (A-S) have been defined [54, 55]. The LOS
locus of BfR-CA-9557 ranges from position 1,332,138 to
1,349,328 (17,190 bp) and contains 17 ORFs. No sialyl-
transferase cstII/III homologue genes and no N-acetylga-
lactosaminyltransferase neuABC homologue genes are
present in this cluster and therefore BfR-CA-9557 ex-
presses an unsialylated LOS. It does not exactly belong
to one of the LOS classes described for C. jejuni but it is
closer related to the LOS classes E, P, O, and H. Remark-
ably, the waaM and waaV homologue genes are imme-
diate neighbours, therefore the established sequencing
approach would have been difficult due to problems re-
solving repetitive genomic regions [54].
Virulence-associated genes
Neither dimethylsulfoxide (DMSO) reductase systems
nor gamma glutamyltranspeptidase (ggt) gene could be
detected in the BfR-CA-9557 genome, which is typical
for a clade 1 C. coli isolates, but three genes homologous
to the iron transport protein TonB were present in the
BfR-CA-9557 genome, which has been reported as typ-
ical for clade 2 and 3 C. coli isolates [13]. The cytolethal
distending toxin (cdt) operon contains all three subunits
and is therewith complete.
Campylobacter jejuni integrated element 1-like element &
CRISPR elements
At position 1,427,993-1,467,476 we could identify a
39,483 bp sized Campylobacter jejuni integrated elem-
ent 1 (CJIE1)-homologue prophage that shows 96 %
identity (at 86 % query coverage) to CJIE1 described
in C. jejuni RM1221 [45]. No CRISPR elements were
found by any method.
Methylation motifs and RM-systems in the genome of C.
coli BfR-CA-9557
In addition to reconstruction of the genome sequence
SMRT sequencing allows determination of base modifi-
cation by analysis of the sequencing kinetics. Using the
SMRT Analysis Modification and Motif detection, we
could identify 45,881 putatively N-6-methylated adenines
(m6A, ~2.7 % of genome), 1788 4-methylated cytosines
(m4C, ~0.1 %) and further 53,350 rather unspecific
“modified bases” where the type of modification was not
recognized by the software (Additional file 5: Figure S3).
Methylated bases were arranged within eight different
dominant methylation motifs (Table 3, Fig. 3). All motifs
are recognized by N-6 adenine-specific methyltransfer-
ases. A small fraction (2.8 %) of m6A bases were not
clustered into any of the motifs, and no consensus motif
could be identified for either m4C-methylated bases or
the majority of other unspecific modified bases.
The motifs G1 & G2 and H1 & H2 (Table 3) are part-
ner motifs and motifs A and B represent palindromic se-
quences, all of these partners containing methylated
bases on both strands. In contrast, bases of motifs C, D,
E, and F were methylated on only one strand. The major
methylation motifs A, B, C, E, G, and H were almost
completely methylated across their occurrences within
the genome. The percentage of methylation ranges from
98.67 % to 99.75 %. In contrast, only 69.69 % of the m6A
methylation motif F sequences were methylated.
Using the recognition sequence search feature within
the Restriction Enzyme Database – REBASE [56], only
two out of the eight motifs (GATC, RAATTY) could be
matched to existing recognition sequences of restriction
systems (both Type II; http://rebase.neb.com/cgi-bin/
pacbioget?17032). The remaining motifs represent yet
















A RAATTY 3 m6A 98.67 27795 28170 309.40 235.73 RAATTY
B GATC 2 m6A 99.66 7512 7538 344.25 257.15 GATC
C RCATC 3 m6A 99.43 4381 4406 274.48 256.54
D CAAGAA 6 m6A 99.71 2069 2075 290.35 249.45
E GGGTDA 6 m6A 99.44 1607 1616 327.70 254.15
F DACATTGB 4 m6A 69.69 223 320 80.60 255.05
G1 TAAANNNNNGTG 3 m6A 99.75 392 393 271.96 259.91 CACNNNNNTTTA
G2 CACNNNNNTTTA 2 m6A 99.75 392 393 331.81 263.02 TAAANNNNNGTG
H1 CAAYNNNNNNNTTYG 3 m6A 99.58 237 238 316.89 246.49 CRAANNNNNNNRTTG
H2 CRAANNNNNNNRTTG 4 m6A 99.58 237 238 276.97 247.15 CAAYNNNNNNNTTYG
1 QV = quality value
Methylation motifs were identified using the PacBio SMRT Analysis software (see Methods). Column 2 shows the sequence consensus of the motif,
whereby non-uniform positions are represented by IUPAC ambiguity codes. Column 3 and 4 denote the position of the modified base within the
motif and the type of methylation. Column 5 represents the fraction of a motif’s occurrences in the genome (column 7) for which a methylation has
been detected (column 6). Column 8 and 9 denote the average modification quality (in Phred Q-scores) and average coverage of motifs detected as
modified. The last column shows the partner motif, i.e. the reverse complement of the motif
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unknown recognition sequences with the longer motifs
(G and H) most likely being specific to C. coli or to this
particular strain.
Using the REBASE sequence search feature and the
NCBI, G2L and Prodigal/Prokka annotations four
ORFs encoding subunits of Type I, seven ORFs en-
coding subunits of Type II, and three ORFs encoding
subunits of Type IV RM-systems have been identified
(Table 4). Only two of the REBASE predicted recogni-
tion sequences correspond to a specific motif detected
by SMRT sequencing, namely: GAATTC/RAATTY
(motif A) recognized by the DNA modification meth-
ylase (Adenine-specific methyltransferase) FokIM_2
(ORF #02605) and GATC (motif B) recognized by the
DNA modification methyltransferase DpnA (ORF
#2895). Additionally REBASE predicts a second candi-
date for a GATC-specific DNA modification methyl-
transferase in ORF #8910. In contrast, RAST and
Prodigal predict a 16S rRNA (guanine(966)-N(2))-
methyltransferase for this ORF.
The two recognition sequences GAGNNNNNGT and
GGATG predicted for the Type I restriction-
modification system2C DNA-methyltransferase subunit
M (ORF #6540) and modification methylase FokI
homologue (ORF #720), respectively, do not correspond
to any motif detected by SMRT sequencing in the gen-
ome of C. coli BfR-CA-9557.
REBASE search hits to the remaining ten RM-
system subunit genes have not been associated with a
specific recognition sequence. Therewith, REBASE
was not able to predict a corresponding RM-system
subunit for the motifs C, D, E, F, G, and H. This is
most likely due to the fact that besides motifs A
(RAATTY) and B (GATC) none of the published C.
jejuni and H. pylori methylomes contains one of these
motifs [49, 50, 57].
Motif B (GATC) is present in the methylomes of H.
pylori 26695 and J99-R3 [57] but not in any of the
publicly available C. jejuni methylomes. In the two H.
pylori genomes ORFs hp0092 and jhp0085 encoding a
RM-system IIM subunit have been assigned to this
motif [58, 59]. The C. coli BfR-CA-9557 homologue
of hp0092 (H. pylori 26695) demonstrates a sequence





Fig. 3 Sequence logos of eight methylation motifs. The consensus sequences of all eight motifs are depicted as sequence logo as obtained by
the WebLogo 3 server (weblogo.threeplusone.com/create.cgi). The height of each stack indicates the degree of conservation (bits). The height of
the letters represents the relative frequency of the base. The asterisk under a particular letter indicates the modified/methylated base. The two
motifs in G and in H are partner motifs that are methylated at both strands. All motifs are recognized by N-6 adenine-specific methyltransferases
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In contrast, the RAATTY motif (A) has not been de-
tected in one of the two H. pylori methylomes, but is
was present in C. jejuni F38011, NCTC 11168 as well as
81–176 and in all three isolates a corresponding RM-
system subunit has been assigned [50, 57]. The C. coli
BfR-CA-9557 homologue of cj0208 (NCTC 11168) dem-
onstrates a sequence identity of 85 % (893/1050; Query
coverage: 95 %).
The biological implications of this particular subset of
RM-systems are difficult to predict, especially since the
majority of methylation motifs and methylases in the
genome of C. coli BFR-CA-9557 are quite novel. From
the closely related bacterial species H. pylori it has been
described in detail that RM-systems play a crucial role in
forming strong barriers to prevent uptake of both plas-
mid and chromosomal DNA [60]. H. pylori bacterial
cells are inherently very competent for DNA uptake, but
this competence for DNA uptake varies significantly be-
tween specific strains. It has been observed that strains
showing a very low endogenous RM-system activity
demonstrate the highest transformation efficiency. Espe-
cially the presence of an RM-system homologous to
MboI, which has been used for isoschizomer digestion
assays in our study, has been described as major compo-
nent of the H. pylori transformation barrier [60]. This
MboI homologous RM-system named HpyIII is highly
conserved among H. pylori strains and mediates protec-
tion against MboI digestion.
In MboI sensitive strains the hpyIIIR gene was found
absent but a homologue to C. jejuni cj1602, namely
hrgA, was detected. HpyIIIR negative but hrgA positive
H. pylori strains have been associated with gastric cancer
in Asian patients, while the pathogenic mechanism re-
mains unclear [61].
Besides this role for DNA uptake the high intra-
species variety in RM-system configuration and there-
with the highly diverse methylation status of H. pylori
chromosomal DNA was suggested to serve as a new








465 + 86828-89146 hsdR, Type I restriction-modification system2C restriction subunit R (EC 3.1.21.3) I/R -
485 + 92205-93437 hsdS, Type I restriction-modification system2C specificity subunit S (EC 3.1.21.3), EcoKI
specificity protein
I/S -
495 + 94709-96196 Type I restriction-modification system2C DNA-methyltransferase subunit M
(EC 2.1.1.72)
I/M -
6540 - 1246404-1250480 Type I restriction-modification system2C DNA-methyltransferase subunit M
(EC 2.1.1.72) / Type I restriction-modification system2C specificity subunit S
(EC 3.1.21.3)
I/MS (GAGNNNNNGT)3,4
720 + 139123-140043 fokIM_1, Modification methylase FokI, (EC 2.1.1.72), homologue to ulcer associated
adenine specific DNA methyltransferase
II/M (GGATG)3
1470 - 275768-271959 Type IIS restriction enzyme Eco57I II/S -
2605 + 488272-489375 DNA modification methylase (Adenine-specific methyltransferase), fokIM_2,
Modification methylase FokI, (EC 2.1.1.72)
II/M GAATTC
2895 + 541751-542602 DNA modification methyltransferase, dpnA, Modification methylase DpnIIB
(EC 2.1.1.72)
II/M GATC
6520 - 1240865-1243951 N-6 adenine specific DNA methyltransferase II/M -
7730 + 1464470-1465285 DNA adenine methylase, dpnM, Modification methylase DpnIIA, EC 2.1.1.72 II/M -
8910 + 1701685-1702374 16S rRNA (guanine(966)-N(2))-methyltransferase (EC 2.1.1.171) II/M GATC5
2225 + 409683-409970 McrBC 5-methylcytosine-specific restriction endonuclease system2C McrB subunit2C
putative
IV/R -
22302 + 409982-411148 McrBC 5-methylcytosine-specific restriction endonuclease system2C McrB_1
subunit2C putative
IV/R -
22302 + 411208-412158 McrBC 5-methylcytosine-specific restriction endonuclease system2C McrB_2
subunit2C putative
IV/R -
2235 + 412124-413494 McrBC 5-methylcytosine-specific restriction enzyme subunit McrC IV/R -
1ORF # according to the NCBI annotation pipeline for RAST and Prodigal ORF # see Additional files 3 and 4
2disrupted ORF
3predicted sequence does not correspond to any motif detected by SMRT sequencing
4According to REBASE ORF #6540 encodes a Type II RM-system
5In contrast to RAST and Prodigal REBASE predicts a second candidate for a GATC-specific DNA modification methyltransferase for this ORF
Restriction modification systems have been identified as outlined in section “Methods”. Column 1 to 3 denote the number, strand direction and genome position
of the ORF as identified by the NCBI annotation pipeline. Column 4 contains the description of the ORF in terms of aggregated annotations from NCBI, RAST and
Prodigal. The type and predicted recognition sequence of the motif are shown in columns 5 and 6
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typing system [62]. This DNA methylation based typing
system may help to discriminate H. pylori isolates and as
well isolates of related bacterial species like C. jejuni or
C. coli for epidemiological and clinical purposes.
Conclusions
The objective of the study was to analyze the methylome
of a clade 1 C. coli isolate using SMRT sequencing. The
C. coli isolate BfR-9557 was tested positive in 5’-
GmATC-3’ specific isoschizomer digestion assays and
hence chosen for SMRT sequencing. Using one SMRT
cell the complete genome of C. coli BfR-CA-9557 was
sequenced and assembled into a single contig of 1.7
Mbp. The genome contains a CJIE1-like element pro-
phage. SMRT Analysis Modification and Motif detection
have identified eleven different dominant methylation
motifs, while 14 RM-system subunits have been identi-
fied using REBASE and three different annotation pipe-
lines. Only two of the REBASE predicted recognition
sequences correspond to a specific motif detected by
SMRT sequencing. The remaining 9 motifs did not cor-
respond to any database record and are therefore char-
acteristic for C. coli or at least for C. coli BfR-CA-9557.
However, no comparable motifs have been described in
the related microbial species C. jejuni or H. pylori.
Methods
Bacterial isolates, culture conditions, DNA extraction and
MLST typing
50 C. coli isolates of different origin were obtained from
the Federal Institute for Risk Assessment (BfR) in Berlin,
Germany. The bacterial isolates were cultured on
Columbia agar base (Merck) supplemented with 5 %
sheep blood (BA) and incubated at 42 °C under micro-
aerophilic conditions (5 % O2, 10 % CO2, 85 % N2) for
18 hours prior to genomic DNA extraction. Genomic
DNA of all C. coli isolates was extracted using the
QIAamp DNA Mini Kit (Qiagen) according to the man-
ufacturer’s instructions.
Species confirmation was performed using MALDI
Biotyper system (Bruker Daltonics, Bremen, Germany).
Results with MALDI Biotyper identification score values
≥2.000 were considered correct. Additionally multiplex
PCR was used to discriminate between C. jejuni and C.
coli [63, 64].
The MLS-type was established using amplification and
sequencing primers reported before [65]. The cycling
conditions were 94 °C for 1 min, followed by 35 cycles
of 94 °C for 120 s, 50 °C for 60 s, 72 °C for 60 s, followed
by a final elongation step of 72 °C for 5 min [65]. Ampli-
cons of the seven genes included in the C. jejuni/C. coli
MLST scheme were sent for sequencing to Seqlab Se-
quence Laboratories GmbH (Göttingen, Germany) using
10 pmol of the respective sequencing primer.
5’-GmATC-3’ specific Isoschizomer digestion assay
Screening for a C. coli strain that methylates adenines in
G(m)ATC sequences was performed using isoschizomer
digestion assays in order to identify a C. coli strain ex-
pressing a Dam homologue. Genomic/chromosomal
bacterial DNA was digested by the three restriction en-
zymes MboI, DpnI and Sau3AI. MboI is responsive to
Dam methylation. Therefore adenosyl-methylated GATC
sequences become refractory to cleavage by MboI but
turn susceptible to DpnI cleavage. Additionally the re-
striction endonuclease Sau3AI that is insensitive to
adenosyl-methylation by the Dam system was used as di-
gestion control [51].
Antimicrobial susceptibility testing
C. jejuni BfR-CA-9557 antimicrobial susceptibility to
quinolones (ciprofloxacin) macrolides (erythromycin),
aminoglycosides (gentamicin, streptomycin) and tetracy-
clines (tetracycline) was tested using the disc diffusion
method according to the standards of the European
Committee on Antimicrobial Susceptibility Testing
(ESCMID) [66] and the microdilution assay according to
the standards of the Clinical and Laboratory Standards
Insitute (CLSI) [67], using cut-off values set by EUCAST
(www.eucast.org). Antimicrobial test discs (ciprofloxacin,
erythromycin, gentamicin, tetracycline) and EUCAMP2
microtiter plates were obtained from Oxoid/Thermo-
Fisher Scientific (Wesel, Germany). For MIC analysis the
Sensititre semiautomated system (Trek Diagnostic Sys-
tems, Inc, Cleveland, Ohio) was used.
Library Preparation and Sequencing
Genomic DNA of C. coli BfR-CA-9557 (DSM 100395) was
extracted using the QIAamp DNA Mini Kit (Qiagen) ac-
cording to the manufacturer’s instructions. The DNA li-
braries have been prepared following the PacBio guidelines
and sequenced on a SMRT cell using Pacific Biosciences RS
sequencing technology (Pacific Biosciences, Menlo Park,
USA) at Functional Genomics Center Zürich (FGCZ,
Switzerland). Input genomic DNA concentration was mea-
sured using a Qubit Fluorometer dsDNA Broad Range
assay (Life Technologies, Carlsbad, USA; p/n 32850). The
SMRT bell was produced using the DNA Template Prep
Kit 1.0 (Pacific Biosciences; p/n 100-259-100). 10 μg of
gDNA were mechanically sheared to an avarage size distri-
bution of 10Kb, using a Covaris gTube (Kbiosciences, Hod-
desdon, UK; p/n 520079). A Bioanalyzer 2100 12 K DNA
Chip assay (Agilent Technologies, Santa Clara, USA; p/n
5067–1508) was used to assess the fragment size distribu-
tion. 5 μg of sheared gDNA were DNA damage repaired
and end-repaired using polishing enzymes. A blunt end
ligation reaction followed by exonuclease treatment was
performed to create the SMRT bell template. A Blue Pippin
device (Sage Science, Beverly, USA) was used to size select
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the SMRT bell template and enrich the big fragments >
8Kbp. The sized selected library was quality inspected and
quantified on the Agilent Bioanalyzer 12Kb DNA Chip and
on a Qubit Fluorimeter.
A ready-to-sequence SMRT bell-polymerase Complex
was created using the P6 DNA/Polymerase binding kit
2.0 (Pacific Biosciences, Menlo Park, USA; p/n 100-236-
500) according to the manufacturer instructions.
The Pacific Biosciences RS2 instrument was pro-
grammed to load and sequence the sample on a single
SMRT cell v3.0 (Pacific Biosciences p/n100-171-800),
taking one movie of 120 minutes.
The MagBead loading method (PacBio, Menlo Park,
USA; p/n 100-133-600) was chosen in order to improve
the enrichment the longer fragments.
At the end of the run, a sequencing report was gener-
ated for every cell, via the SMRT portal. Thereby, the
adapter dimer contamination, the sample loading effi-
ciency, the obtained average read-length and the number
of filtered sub-reads have been assessed.
Sequence analysis
Processing of the raw SMRT cell data was performed
using the Pacific Biosciences SMRT Analysis System
(version 2.3, January 2015; PacBio, Menlo Park, USA).
For de novo assembly of the C. coli BFR-CA-9557 gen-
ome the high-quality Hierarchical Genome Assembly
Process (RS_HGAP_Assembly.2) was used with standard
parameters (for details on algorithms please read https://
github.com/PacificBiosciences/Bioinformatics-Training/
wiki/HGAP-in-SMRT-Analysis).
The assembled genome was annotated using the rapid
annotation using subsystem technology platform (RAST,
http://rast.nmpdr.org) [68–70] and the Prodigal/Prokka
annotation pipeline [71] implemented at Göttingen Gen-
ome Laboratory (G2L).
For identification of methylated bases and modification
motifs the RS_Modification_and_Motif_Analysis.1 protocol
within the SMRT Analysis System was used with standard
parameters on the basis of the previously assembled genome.
Putative restriction modification systems have been
identified using the Restriction-ModificationFinder-1.0
server (https://cge.cbs.dtu.dk/services/Restriction-Modi-
ficationFinder-1.0/) based on the Restriction Enzyme
database (REBASE, http://rebase.neb.com/rebase/reba-
se.html) [56].
Additionally, homologues of published Campylobacter
and Helicobacter restriction modification [46–50] sys-
tems have been identified by BLAST search.
Additional checking for clustered regularly interspaced
short palindromic repeats (CRISPRs) and CRISPR-




Ethical clearance for the analysis was obtained from Eth-
ics Committee of the University Medical Center Göttin-
gen, Germany. As the bacterial isolates from human
donors were already part of an anonymized strain collec-
tion and no evaluation including personal patient data
has been performed the Ethics Committee of the Univer-
sity Medical Center Göttingen waived the need for writ-
ten informed consent from the donor or the next of kin.
Availability of supporting data
The genome is available at NCBI as Campylobacter
coli BFR-CA-9557 with AB430 locus tags (BioProject
Accession: PRJNA285481 ID: 285481; BioSample:
SAMN03754337; GenBank ID: CP011777). Additionally
RM-system and methylation motifs can be accessed via
the index of the REBASE database (http://tools.neb.com/
genomes/) or directly via this link: http://tools.neb.com/
genomes/view.php?view_id=35944.
The bacterial isolate Campylobacter coli BFR-CA-9557
was deposited in the strain collection of the Leibniz-
Institut DSMZ-Deutsche Sammlung von Mikroorganis-
men und Zellkulturen GmbH, Braunschweig, Germany
(German Collection of Microorganisms and cell cul-
tures); isolate ID: DSM 100395.
Additional files
Additional file 1: Figure S1. SMRT sequencing of Campylobacter coli
BFR-CA-9557. (A) Read length distribution of 74,742 continuous long
reads (CLR) obtained from a single SMRT cell after filtering for low quality.
The black line depicts the cumulated amount of bases covered by reads
of a minimum size as shown on the x-axis. (B) Distribution of read quality
values (1 = 100 %) for 74,742 CLRs after filtering. The black line denotes
the average length of reads with a quality at least as good as indicated
on the x-axis. (C) Subread length distribution of 142,135 subreads
(i.e. individual fragments of CLRs). (DOC 74 kb)
Additional file 2: Figure S2. Reference Coverage. (A) Reference
coverage (number of read base pairs per position) of the polished
assembly across the contig comprising 1,720,506 bp. Average reference
coverage is 500.8-fold. (B) Histogram of reference coverage across the
assembled contig. (DOC 73 kb)
Additional file 3: RAST annotation of theC. coli BFR-CA-9557.
Annotation of the C. coli BFR-CA-9557 genome using the rapid annotation
using
subsystem technology platform (RAST, http://rast.nmpdr.org). (XLS 3605 kb)
Additional file 4: Prodigal annotation of theC. coli BFR-CA-9557.
Annotation of the C. coli BFR-CA-9557 genome using the Prodigal/Prokka
annotation pipeline. (XLS 727 kb)
Additional file 5 Figure S3. Methylated bases in C. coli BFR-CA-9557.
(A) Scatter plot of modification quality values and per-strand coverage of
101,019 bases detected as methylated in the C. coli BFR-CA-9557
genome. (B) Histogram of modification quality values for all bases.
(DOC 115 kb)
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